Moreover, RI-BPI also displayed good inhibition in the treatment of BCR type cell line xenografted mice model and primary human BCL6 expressing DLBCL (Cerchietti et al., 2009). The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.